FDA OKs Cephalon's Fentora

Cephalon (CEPH - news - Cramer's Take) said late Monday that it received government approval to begin marketing a cancer-pain drug, Fentora.

The company announced that the Food and Drug Administration had endorsed the drug for patients who are receiving -- and who can tolerate -- opioid therapy. Fentora's label carries the agency's strongest warning about the dangers of abusing the drug, which is classified in the same category as powerful drugs like morphine and methadone.